VOLPINI, Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.271
EU - Europa 8.341
AS - Asia 5.751
SA - Sud America 875
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 50
OC - Oceania 11
Totale 32.398
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.707
CN - Cina 2.622
RU - Federazione Russa 1.953
SG - Singapore 1.637
PL - Polonia 1.535
IT - Italia 1.293
DE - Germania 923
BR - Brasile 752
GB - Regno Unito 538
UA - Ucraina 536
SE - Svezia 519
CA - Canada 501
HK - Hong Kong 477
FR - Francia 311
FI - Finlandia 304
KR - Corea 227
TR - Turchia 214
VN - Vietnam 183
IE - Irlanda 129
IN - India 98
JP - Giappone 66
EU - Europa 49
BE - Belgio 48
AR - Argentina 46
MX - Messico 45
NL - Olanda 45
ZA - Sudafrica 43
ES - Italia 40
CZ - Repubblica Ceca 37
BD - Bangladesh 33
IR - Iran 31
AT - Austria 28
EC - Ecuador 22
IQ - Iraq 19
RO - Romania 17
UZ - Uzbekistan 15
AE - Emirati Arabi Uniti 14
CO - Colombia 14
ID - Indonesia 13
LT - Lituania 12
SA - Arabia Saudita 12
CH - Svizzera 11
IL - Israele 11
MA - Marocco 11
RS - Serbia 11
CL - Cile 10
TN - Tunisia 10
TW - Taiwan 10
VE - Venezuela 10
KE - Kenya 9
PE - Perù 9
AZ - Azerbaigian 8
JO - Giordania 8
PK - Pakistan 8
PY - Paraguay 8
DK - Danimarca 7
DZ - Algeria 7
AU - Australia 6
BG - Bulgaria 6
LB - Libano 6
AM - Armenia 5
EG - Egitto 5
LV - Lettonia 5
PH - Filippine 5
GE - Georgia 4
GR - Grecia 4
HR - Croazia 4
KZ - Kazakistan 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
TH - Thailandia 4
AL - Albania 3
BO - Bolivia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
EE - Estonia 3
KH - Cambogia 3
LU - Lussemburgo 3
NO - Norvegia 3
BY - Bielorussia 2
CM - Camerun 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GT - Guatemala 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BT - Bhutan 1
DM - Dominica 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 32.381
Salva come PNG Salva come JPEG
Città #
Fairfield 1.762
Woodbridge 1.493
Warsaw 1.335
Jacksonville 1.322
Ashburn 1.309
Houston 1.058
Chandler 1.053
Seattle 781
Wilmington 753
Singapore 682
Ann Arbor 647
Cambridge 605
Boardman 563
Dallas 548
Hong Kong 462
Nanjing 461
Beijing 393
Toronto 328
Camerino 243
The Dalles 241
Los Angeles 236
Seoul 204
San Mateo 199
Columbus 189
Tongling 189
Dearborn 188
Kraków 185
Lawrence 180
Princeton 180
Düsseldorf 175
New York 173
Istanbul 166
Ogden 146
Dublin 128
Lachine 128
Buffalo 123
London 123
Moscow 123
Nanchang 123
Helsinki 112
Shanghai 99
Shenyang 90
Chicago 88
Munich 88
Milan 84
San Diego 84
Tianjin 84
Guangzhou 82
São Paulo 82
Kunming 74
Council Bluffs 69
Hebei 62
Ho Chi Minh City 57
Jiaxing 56
Santa Clara 52
Tokyo 51
Brussels 48
Frankfurt am Main 43
Changsha 40
Jinan 39
Redwood City 39
Wuhan 39
Ningbo 38
Hanoi 37
Rome 37
Centro 36
Hangzhou 36
Dong Ket 35
Phoenix 34
Denver 31
Turku 31
Venezia 31
Stockholm 30
Zhengzhou 30
Philadelphia 29
Verona 29
San Francisco 28
Hefei 27
Orem 27
Atlanta 26
Brooklyn 26
Johannesburg 26
Poplar 26
Rio de Janeiro 26
Brno 25
Chennai 25
Falls Church 25
Norwalk 25
Boston 24
Orange 24
Redondo Beach 23
Detroit 22
Jinhua 22
Kocaeli 22
Nürnberg 22
Montreal 21
Salt Lake City 21
Taizhou 21
Belo Horizonte 20
Bremen 20
Totale 21.797
Salva come PNG Salva come JPEG
Nome #
1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure–affinity relationships and molecular modeling studies 616
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 404
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 382
Overview on Radiolabel-Free in Vitro Assays for GPCRs 378
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 353
Pharmacological characterization of the GPR17 receptor dual profile 352
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 339
The G Protein-Coupled Receptor GPR17: Overview and Update 323
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 323
GPR17 receptor modulators and their therapeutic implications: review of recent patents 276
Medicinal chemistry and pharmacology of A2B adenosine receptors 274
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 270
8-(2-Furyl)adenine derivatives as A2A adenosine receptor ligands 270
Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones 265
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease 262
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 261
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 251
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 250
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 248
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 246
2-Aralkynyl and 2-Heteroalkynyl derivatives of Adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists 243
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 235
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 231
2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors 230
Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1 227
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases 227
Human placenta cytidine deaminase: a zinc metalloprotein 225
2-Substituted N-ethylcarboxamidoadenosine derivatives as high affinity agonists at human A(3) adenosine receptors 224
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 224
3'-Deoxyribofuranose derivatives of 1-deaza and 3-deaza adenosine and their activity as adenosine deaminase inhibitors 223
9-ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities 222
Biomarkers mapping of neuropathic pain in a nerve chronic constriction injury mice model 222
Human cytidine deaminase: understanding the catalytic mechanism 220
A(2A) adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats 219
Isoenzymatic forms of human cytidine deaminase 218
Determination of ink photoinitiators in packaged beverages by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry 216
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs 214
Purine and deazapurine nucleosides: synthetic approaches, molecular modeling and biological activity 212
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 212
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 211
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 211
Adenosine deaminase: Functional implications and different classes of inhibitors 208
New sensible method to quantize the intestinal absorption of receptor ligands 208
2-Alkynyl derivatives of Adenosine-5'-N-ethyluronamide (NECA): selective A2 adenosine receptor agonists with potent inhibitory activity on Platelet aggregation 207
Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 207
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles 206
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A(2A) and A(2B) receptors ligands 206
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 205
Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation 201
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 200
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 200
Antiviral properties of deazaadenine nucleoside derivatives 199
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 198
CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes. 198
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 198
2- And 8- alkynyladenosines: conformational studies and docking to human adenosine A(3) receptor can explain their different biological behavior 196
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 195
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 195
Antiviral activity of purine nucleoside analogs against bovine herpesvirus (BHV-1) and maedi visna virus (MVV) 194
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 192
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 192
Diazepinone nucleosides as inhibitors of cytidine deaminase 191
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 191
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors 190
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family 190
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 188
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 188
Adenosine receptor modeling: what does the A2A crystal structure tell us? 187
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 186
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor 186
Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases 186
"N-Cycloalkylalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists at the A1 adenosine receptor 184
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 183
New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile 181
Synthesis and receptor affinity of polysubstituted adenosines 180
Chemical and pharmacological profile of selective adenosine receptor agonists 180
2-phenylhydroxypropynyladenosine derivatives as high potent agonists at A(2B) adenosine receptor subtype 179
2-substituted 5 '-N-methylcarboxamidoadenosine (MECA) derivatives as A(3) adenosine receptor ligands 179
Ring opening reactions: synthesis of AICAR analogs as potential antimetabolite agents 178
2- And 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosines receptors 177
GPCRs as therapeutic targets: a view on adenosine receptors structure and functions, and molecular modeling support 176
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 175
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 175
Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor 174
Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity 173
Synthesis and adenosine deaminase inhibitory activity of 3’-deoxy-1-deazaadenosines 173
Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors Ranging from Pan Ligands to Combined A1/A2B Partial Agonists 173
Potent and selective ligands for adenosine binding sites 172
Unexpected synthesis of acyclic adenine nucleosides 171
A(2B) adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyladenosine and NECA derivatives 169
[3H]HEMADO – a novel tritiated agonist selective for the human adenosine A(3) receptor 169
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 168
Pharmacological postconditioning of the rabbit heart with non-selective, A1, A2A and A3 adenosine receptor agonists 167
Coupling of 2,6-disubstituted purines to ribose-modified sugars 166
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide 165
2-ChloroATP exerts anti-tumoral actions not mediated by P2 receptors in neuronal and glial cells line 165
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A1 adenosine receptor 165
Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine 164
Well water in central Italy: Analysis of herbicide residues as potential pollutants of untreated crops 162
Structure-activity relationships of adenosine deaminase inhibitors 162
Totale 21.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.871 0 0 0 0 0 463 731 113 364 210 602 388
2021/20222.229 234 534 55 91 122 119 102 167 170 235 157 243
2022/20232.525 256 144 76 420 277 361 11 154 461 134 165 66
2023/20241.883 265 100 110 76 87 173 87 104 222 62 49 548
2024/20256.213 231 140 527 295 200 361 709 1.540 518 436 382 874
2025/20264.567 538 524 1.072 1.240 984 209 0 0 0 0 0 0
Totale 32.855